Low-grade fibromyxoid sarcoma versus low-grade myxofibrosarcoma in the extremities and trunk. A comparison of clinicopathological and immunohistochemical features

Histopathology

Volumn 45, Issue 1, 2004, Pages 29-38

  Oda, Y ^a   Takahira, T ^a   Kawaguchi, K ^a   Yamamoto, H ^a   Tamiya, S ^a   Matsuda, S ^a   Tanaka, K ^a   Iwamoto, Y ^a   Tsuneyoshi, M ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Cell cycle regulators; Immunohistochemistry; Low grade fibromyxoid sarcoma; Myxofibrosarcoma; Myxoid malignant fibrous histiocytoma

Indexed keywords

CYCLIN A; CYCLIN D1; CYCLIN E; KI 67 ANTIGEN; PROTEIN MDM2; PROTEIN P16; PROTEIN P21; PROTEIN P27; PROTEIN P53; REGULATOR PROTEIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER LOCALIZATION; CELL CYCLE; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOPATHOLOGY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FIBROSARCOMA; FREQUENCY ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABELING INDEX; LOW GRADE FIBROMYXOID SARCOMA; LOW GRADE MYXOFIBROSARCOMA; MALE; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; STATISTICAL SIGNIFICANCE; TUMOR NECROSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CELL CYCLE PROTEINS; CHILD; CYCLIN A; CYCLIN D1; CYCLIN E; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; FEMALE; FIBROSARCOMA; FOREARM; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LEG; MALE; MIDDLE AGED; SHOULDER; THIGH; TUMOR SUPPRESSOR PROTEINS;

EID: 3242790798     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2004.01886.x     Document Type: Article

References (24)

1. Evans HL. Low-grade fibromyxoid sarcoma. A report of two metastasizing neoplasms having a deceptively benign appearance. Am. J. Clin. Pathol. 1987; 88; 615-619.
2. Evans HL. Low-grade fibromyxoid sarcoma. A report of 12 cases. Am. J. Surg. Pathol. 1993; 17; 595-600.
3. Goodlad JR, Mentzel T, Fletcher CDM. Low-grade fibromyxoid sarcoma: clinicopathological analysis of eleven new cases in support of a distinct entity. Histopathology 1995; 26; 229-237.
4. Weiss SW, Goldblum JR. Low-grade fibromyxoid sarcoma. In Weiss SW, Goldblum JR eds. Enzinger and Weiss's soft tissue tumors, 4th edn. St Louis, MO: Mosby, 2001; 425-435.
5. Folpe A, van den Berg E, Molenaar WM. Low grade fibromyxoid sarcoma. In Fletcher CDM, Unni KK, Mertens F eds. WHO classification of tumors. Pathology and genetics. Tumors of soft tissue and bone, 1st edn. Lyon: IARC Press, 2002; 104-105.
6. Angervall L, Kindblom LG, Merck C, Myxofibrosarcoma. A study of 30 cases. Acta Pathol. Microbiol. Scand. (A) 1977; 85; 127-140.
7. Mentzel T, Calonje E, Wadden C et al. Myxofibrosarcoma. Clinicopathologic analysis of 75 cases with emphasis on low-grade variant. Am. J. Surg. Pathol. 1996; 20; 391-405.
8. Guillou L, Coindre JM, Bonichon F et al. Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. J. Clin. Orccol. 1997; 15; 350-362.
9. Dei Tos AP, Piccinin S, Doglioni C et al. Molecular aberrations of the G1-S checkpoint in myxoid and round cell liposarcoma. Am. J. Pathol. 1997; 151; 1531-1539.
10. Antonescu CR, Leung DH, Dudas M et al. Alterations of cell cycle regulators in localized synovial sarcoma. A multifactorial study with prognostic implications. Am. J. Pathol. 2000; 156; 977-983.
11. Noguchi T, Dobashi Y, Minehara H, Itoman M, Kameya T. Involvement of cyclins in cell proliferation and their clinical implications in soft tissue smooth muscle tumors. Am. J. Pathol. 2000; 156; 2135-2147.
12. Kawauchi S, Goto Y, Liu X-P et al. Low expression of p27Kip1, a cyclin-dependent kinase inhibitor, is a marker of poor prognosis in synovial sarcoma. Cancer 2001; 91; 1005-1012.
13. Weiss SW, Sobin L eds. WHO histological typing of soft tissue tumours, 2nd edn. Berlin, Heidelberg: Springer-Verlag, 1994.
14. Lane KL, Shannon RJ, Weiss SW. Hyalinizing spindle cell tumor with giant rosettes. A distinctive tumor closely resembling low-grade fibromyxoid sarcoma. Am. J. Surg. Pathol. 1997; 21; 1481-1488.
15. Folpe AL, Lane KL, Paull G, Weiss SW. Low-grade fibromyxoid sarcoma and hyalinizing spindle cell tumor with giant rosettes. A Clinicopathologic study of 73 cases supporting their identity and assessing the impact of high-grade areas. Am. J. Surg. Pathol. 2000; 24; 1353-1360.
16. American Joint Committee on Cancer. AJCC cancer staging manual, 5th edn. Philadelphia, PA: Lippincott-Raven, 1997.
17. Kratzke RA, Greatens TM, Rubins JB et al. Rb and p16 INK4a expression in resected non-small cell lung tumors. Cancer Res. 1996; 56; 3415-3120.
18. Reid R, de Silva MVC, Paterson L et al. Low-grade fibromyxoid sarcoma and hyalinizing spindle cell tumor with giant rosettes share a common t(7;16)(q34;p11) translocation. Am. J. Surg. Pathol. 2003; 27; 1229-1236.
19. Weiss SW, Goldblum JR, Malignant fibrous histiocytoma: myxoid type. In Weiss SW, Goldblum JR eds. Enzinger and Weiss's soft tissue tumors, 4th edn. St Louis, MO: Mosby, 2001; 550-558.
20. Orlow I, Drobnjak M, Zhang ZF et al. Alterations of INK4A and INK4B genes in adult soft tissue sarcomas: effect on survival. J. Natl Cancer Inst. 1999; 91; 73-79.
21. El-Deiry WS, Tokino T, Velculescu VE et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75; 817-825.
22. Del Sal G, Loda M, Pagano M. Cell cycle and cancer: critical events at the G1 restriction point. Crit. Rev. Oncog. 1996; 7; 127-142.
23. Toyoshima H, Hunter T. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 1994; 78; 67-74.
24. Lloyd RV, Erickson LA, Jin L et al. p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am. J. Pathol. 1999; 154; 313-323.